BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, providing promising improvements throughout several health care and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, much more reputable substitute for therapeutic